Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

JNK1 Inhibitors

JNK1 inhibitors belong to a class of chemical compounds designed to target and inhibit the activity of c-Jun N-terminal kinase 1 (JNK1), a member of the mitogen-activated protein kinase (MAPK) family. These inhibitors are crucial tools in the field of molecular biology and cellular research, as they help elucidate the intricate signaling pathways that involve JNK1. JNK1 itself is a serine/threonine kinase that plays a pivotal role in regulating various cellular processes, including apoptosis, inflammation, and cellular response to stressors. By developing specific inhibitors for JNK1, researchers can investigate the precise roles of this kinase in different cellular contexts and better understand its contribution to various diseases. Chemically, JNK1 inhibitors are designed to interact with the active site of JNK1, preventing its phosphorylation of downstream substrates. This inhibition disrupts the signaling cascade that JNK1 is involved in, allowing researchers to probe the effects on cell behavior. These compounds can be used in in vitro experiments to study cell signaling pathways, gene expression, and cellular responses to stress or injury. Understanding the intricacies of JNK1 regulation through these inhibitors can provide valuable insights into the molecular mechanisms underlying diseases such as cancer, neurodegenerative disorders, and inflammatory conditions. Researchers often employ a variety of JNK1 inhibitors with varying selectivity and potency to tailor their experiments to specific research questions, making this class of compounds an essential component of modern molecular biology and cellular research.

SEE ALSO...

Items 11 to 13 of 13 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

JNK Inhibitor XI

2207-44-5sc-364743
10 mg
$150.00
(0)

JNK Inhibitor XI is a selective antagonist of JNK1, characterized by its ability to disrupt critical phosphorylation events within cellular signaling pathways. It exhibits a unique binding affinity that alters the enzyme's conformational dynamics, preventing activation. The inhibitor's distinct structural features promote specific interactions with the ATP-binding site, leading to a notable reduction in catalytic efficiency. Its reaction kinetics indicate a competitive inhibition mechanism, providing insights into its regulatory potential in cellular processes.

Doramapimod

285983-48-4sc-300502
sc-300502A
sc-300502B
25 mg
50 mg
100 mg
$149.00
$281.00
$459.00
2
(1)

BIRB 796 is a JNK inhibitor that competes with ATP for binding to JNK1. It impedes JNK-mediated signaling pathways, reducing inflammation and cellular stress responses.

CC-401

395104-30-0sc-364748
sc-364748A
2 mg
10 mg
$331.00
$1060.00
4
(1)

CC-401 is an ATP-competitive JNK inhibitor. It blocks the activation of JNK1, preventing the phosphorylation of c-Jun and other downstream effectors in the JNK pathway.